Lawrence Eichenfield, M.D.

Specialty

Dermatology

Organization

Rady Children's Specialists of San Diego

Medical Group / IPA

Rady Children's Specialists

Medical School

Mount Sinai School of Medicine

Internship

Children's Hospital of Philadelphia

Residency

Children's Hospital of Philadelphia

Board Certifications

Dermatology, Pediatric Dermatology, Pediatrics

Gender

M

Bio

Dr. Lawrence Eichenfield is chief of pediatric and adolescent dermatology at Rady Children's Hospital-San Diego, as well as vice chair of the Department of Dermatology and a professor of dermatology and pediatrics at UC San Diego School of Medicine.

Dr. Eichenfield earned his medical degree from Mount Sinai School of Medicine in New York, was a pediatric resident and chief resident at Children's Hospital of Philadelphia, and completed dermatology training at the hospital of the University of Pennsylvania. He is board certified in pediatrics, dermatology and pediatric dermatology.

Dr. Eichenfield's clinical interests include atopic dermatitis, acne, psoriasis, vascular legions including port wine stains and hemangiomas, neonatal dermatology, laser surgery, nevi and skin signs of systemic disease. He has authored more than 300 journal articles, chapters, abstracts and books on these topics and serves on the editorial boards of multiple journals and periodicals. Along with being editor-in-chief of Pediatric Dermatology, he has served as senior editor for "Neonatal and Infant Dermatology," published by Elsevier, and "The Eczemas," published by Summit Communications.

He has been honored as a member of the Alpha Omega Alpha Honor Society during medical school, and as a recipient of the Benjamin Ritter Award at Children's Hospital of Philadelphia and excellence in teaching awards from UC San Diego Pediatrics, UC San Diego Dermatology and Rady Children's.

Dr. Eichenfield is past president of the Society for Pediatric Dermatology, has served on the board of the American Academy of Dermatology, and served as chair for the 69th Annual Meeting of the American Academy of Dermatology. He is also a founding board member of the American Acne & Rosacea Society and is a founder and co-chair of the Pediatric Dermatology Research Alliance, a collaborative research network.

He has been named one of the "Best Doctors in America" since 1994.

Publications

Treatment of Pediatric Treadmill Burn Contractures With Ablative Fractional Laser and Topical Triamcinolone Suspension.
Tu JH, Udkoff JA, Eichenfield LF

Primary cutaneous aspergillosis at the site of cyanoacrylate skin adhesive in a neonate.
Kusari A, Sprague J, Eichenfield LF, Matiz C, Barrio VR

Transforming acne care by pediatricians: An interventional cohort study.
Borok J, Udkoff J, Vaida F, Murphy J, Torriani F, Waldman A, Ahluwalia J, Eichenfield LF

Introduction.
Eichenfield LF

Atopic Dermatitis.
Waldman AR, Ahluwalia J, Udkoff J, Borok JF, Eichenfield LF

Developing drugs for treatment of atopic dermatitis in children (≥3 months to <18 years of age): Draft guidance for industry.
Siegfried EC, Jaworski JC, Eichenfield LF, Paller A, Hebert AA, Simpson EL, Altman E, Arena C, Blauvelt A, Block J, Boguniewicz M, Chen S, Cordoro K, Hanna D, Horii K, Hultsch T, Lee J, Leung DY, Lio P, Milner J, Omachi T, Schneider C, Schneider L, Sidbury R, Smith T, Sugarman J, Taha S, Tofte S, Tollefson M, Tom WL, West DP, Whitney L, Zane L

Quality of Life in Individuals with Erythematotelangiectatic and Papulopustular Rosacea: Findings From a Web-based Survey.
Zeichner JA, Eichenfield LF, Feldman SR, Kasteler JS, Ferrusi IL

A Note from the Journal's Editors-in-Chief.
Frieden IJ, Eichenfield LF

Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE).
Simpson EL, Flohr C, Eichenfield LF, Bieber T, Sofen H, Taïeb A, Owen R, Putnam W, Castro M, DeBusk K, Lin CY, Voulgari A, Yen K, Omachi TA

Pediatric psoriasis: Evolving perspectives.
Eichenfield LF, Paller AS, Tom WL, Sugarman J, Hebert AA, Friedlander SF, Siegfried E, Silverberg N, Cordoro KM

Analyzing the Genetic Spectrum of Vascular Anomalies with Overgrowth via Cancer Genomics.
Siegel DH, Cottrell CE, Streicher JL, Schilter KF, Basel DG, Baselga E, Burrows PE, Ciliberto HM, Vigh-Conrad KA, Eichenfield LF, Holland KE, Hogeling M, Jensen JN, Kelly ME, Kim W, King DM, McCuaig C, Mueller KA, Pope E, Powell J, Price H, Steiner JE, Frieden IJ, Tollefson MM, Drolet BA

Cost-Effectiveness Analysis of Ixekizumab vs Etanercept and Their Manufacturer-Recommended Dosing Regimens in Moderate to Severe Plaque Psoriasis.
Udkoff J, Eichenfield LF

Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging Therapies.
Boguniewicz M, Alexis AF, Beck LA, Block J, Eichenfield LF, Fonacier L, Guttman-Yassky E, Paller AS, Pariser D, Silverberg JI, Lebwohl M

Atopic dermatitis: therapeutic care delivery: therapeutic education, shared decision-making, and access to care.
LeBovidge J, Borok J, Udkoff J, Yosipovitch G, Eichenfield LF

Atopic dermatitis: emerging therapies.
Simpson E, Udkoff J, Borok J, Tom W, Beck L, Eichenfield LF

Atopic dermatitis: skin care and topical therapies.
Fleischer DM, Udkoff J, Borok J, Friedman A, Nicol N, Bienstock J, Lio P, Tollefson MM, Eichenfield LF

Atopic dermatitis: pathogenesis.
Guttman-Yassky E, Waldman A, Ahluwalia J, Ong PY, Eichenfield LF

Curriculum United for Better Eczema Care: why, how, and what?
Eichenfield LF, Ahluwalia J, Davis DM, Fleischer DM, Waldman A, Spergel J

Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis.
Eichenfield LF, Call RS, Forsha DW, Fowler J Jr, Hebert AA, Spellman M, Stein Gold LF, Van Syoc M, Zane LT, Tschen E

When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council.
Simpson EL, Bruin-Weller M, Flohr C, Ardern-Jones MR, Barbarot S, Deleuran M, Bieber T, Vestergaard C, Brown SJ, Cork MJ, Drucker AM, Eichenfield LF, Foelster-Holst R, Guttman-Yassky E, Nosbaum A, Reynolds NJ, Silverberg JI, Schmitt J, Seyger MMB, Spuls PI, Stalder JF, Su JC, Takaoka R, Traidl-Hoffmann C, Thyssen JP, van der Schaft J, Wollenberg A, Irvine AD, Paller AS

Highlights of Skin Disease Education Foundation's 41st Annual Hawaii Dermatology Seminarâ„¢.
Gordon KB, Leonardi CL, Furst DE, Bhatia N, Eichenfield LF, Beleznay K

Current and emerging topical therapies for atopic dermatitis.
Udkoff J, Waldman A, Ahluwalia J, Borok J, Eichenfield LF

Phosphodiesterase 4 Inhibitor Therapies for Atopic Dermatitis: Progress and Outlook.
Ahluwalia J, Udkoff J, Waldman A, Borok J, Eichenfield LF

Isotretinoin and Timing of Procedural Interventions: A Systematic Review With Consensus Recommendations.
Spring LK, Krakowski AC, Alam M, Bhatia A, Brauer J, Cohen J, Del Rosso JQ, Diaz L, Dover J, Eichenfield LF, Gurtner GC, Hanke CW, Jahnke MN, Kelly KM, Khetarpal S, Kinney MA, Levy ML, Leyden J, Longaker MT, Munavalli GS, Ozog DM, Prather H, Shumaker PR, Tanzi E, Torres A, Velez MW, Waldman AB, Yan AC, Zaenglein AL

Addressing the immunopathogenesis of atopic dermatitis: advances in topical and systemic treatment.
Eichenfield LF, Stein Gold LF

See the full listing of this physician's publications on PubMed, a service of the National Library of Medicine.

PubMed is a third-party website and not affiliated with Rady Children's Hospital-San Diego.

Rady Children's updates the Doctor Finder annually. We are not responsible for omissions or errors. Prior to making an appointment, please be sure to check with your health plan to confirm coverage. If you see an error or omission on a physician's profile page, please contact us at refsvc@rchsd.org.